A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.
Oncobone Ventures Ltd. and Origenis GmbH have signed a framework agreement to develop novel therapies targeting cancer bone metastasis. Origenis leverages its artificial intelligence (AI)-driven ...
The new occurrences of cancer are called metastases. A phenotypic study to examine the distinct morphologies of ER+ and ER− breast cancer bone metastases focusing on the mechanism associated ...
ZetaMet™ (Zeta-BC-003) is a synthetic, small-molecule, delivered via a proprietary controlled- release carrier intended to resolve metastatic breast cancer bone lesions, inhibit pain while ...
The incidence of stomach cancer has been rising, with over 40% of patients presenting with metastases at the time of diagnosis. This trend underscores the importance of early detection and timely ...